Bio-Rad Laboratories (BIO) Income from Continuing Operations (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Income from Continuing Operations data on file, last reported at 527100000.0 in Q1 2026.

• On a quarterly basis, Income from Continuing Operations fell 923.59% year-over-year to 527100000.0 in Q1 2026; TTM through Mar 2026 was 168800000.0, a 107.8% increase from a year earlier, with the FY2025 full-year figure at 759900000.0, up 141.2% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 527100000.0, down from 720000000.0 in the prior quarter.
• Over the last five years, Income from Continuing Operations for BIO reached as high as 827814000.0 in Q4 2022 and fell as low as 3367347000.0 in Q1 2022.
• Historically, Income from Continuing Operations has averaged 345654058.82 across 5 years, with a median of 64000000.0 in 2025.
• Across the five-year window, Income from Continuing Operations surged 514.74% in 2024 and sank 923.59% in 2026, its largest moves.
• Year by year, Income from Continuing Operations stood at 827814000.0 in 2022, then tumbled by 57.75% to 349736000.0 in 2023, then tumbled by 304.67% to 715800000.0 in 2024, then jumped by 200.59% to 720000000.0 in 2025, then slumped by 173.21% to 527100000.0 in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were 527100000.0 in Q1 2026, 720000000.0 in Q4 2025, and 341900000.0 in Q3 2025.